Longest follow-up of patients with early breast cancer shows radiotherapy does not improve survival after 30 years

Biochemistry laboratory research, Scientist or medical in lab coat holding test tube with Using Microscope reagent with drop of color liquid over glass equipment working at the laboratory.

Radiotherapy after breast-conserving surgery in conjunction with chemotherapy or tamoxifen to treat early breast cancer reduces the risk of the disease returning in the same breast in the next ten years, but makes little difference to that risk thereafter, nor does it improve overall survival after 30 years.

Best mattress deals as of Nov. 17: Save on popular brands like Casper and more

Previous article

Time-restricted eating reduces body mass in young athletic men

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations